Urology News and Research

Latest Urology News and Research

Inherited variations in mitochondrial DNA linked to renal and prostate cancer

More than 20 million men in the United States with a particular signature set of inherited characteristics and mutations in mitochondrial DNA (mtDNA) are at significantly increased risk for developing renal and prostate cancers, according to research at Emory University.

20 Apr 2005

Innovative urine test for highly specific prostate cancer gene shows promise

Gen-Probe's prototype urine test for PCA3 gene expression may help improve the diagnosis of prostate cancer, according to three early-stage studies presented as posters at the American Association for Clinical Chemistry's 37th Annual Oak Ridge Conference and the Annual Meeting of the American Association for Cancer Research (AACR).

20 Apr 2005

cT3 prostate cancer is operable

New findings from Mayo Clinic indicate that cT3 prostate cancer, a disease in which the cancer has spread locally from inside the prostate to immediately outside it, is operable and has 15-year cancer survival rates of almost 80 percent.

3 Apr 2005

New prostate cancer test

Tessera, Inc., a Seattle-based biomedical company, has released its first product, ProstaMark EPCA (Early Prostate Cancer Antigen), as an Analyte Specific Reagent (ASR) for commercial use in pathology laboratories to assist pathologists in their efforts to determine if cancer is present in the prostate.

28 Mar 2005

KCP protein protects kidneys from damage caused by chronic renal disease and injury

University of Michigan scientists have identified a new and unusual protein that reduces, in laboratory mice, kidney damage caused by chronic renal disease and acute toxic injuries.

28 Mar 2005

Relief for overactive bladder patients

New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.

17 Mar 2005

Uncertainty about the need for prostate cancer

Initial results from an ongoing study evaluating the benefit of prostate cancer screening practices demonstrate that the combined use of both standard tests - the prostate-specific antigen (PSA) blood test and the digital rectal exam (DRE) - is optimal for detecting cancer.

16 Mar 2005

Tumor-targeted immune cells cure prostate cancer without causing systemic immune suppression

In a major breakthrough in cancer gene therapy, a Northwestern University researcher has endowed immune cells with the ability to specifically target metastatic prostate cancer in mice without causing the toxic immune suppression that has been associated with earlier forms of cancer gene therapy.

14 Mar 2005

Prostate screenings could be used to encourage colon checks

Colon cancer is the third leading cause of cancer death in men, but according to a new University of Michigan Health System study, fewer than half of men surveyed were up-to-date with colon cancer screenings.

3 Mar 2005

U.S. cancer researchers launch first American-Israeli cancer conference

Leading cancer researchers from Baltimore, Miami and New Jersey have organized the first Joint American-Israeli Conference on Cancer. The meeting, scheduled for March 16 through 18 in Jerusalem, seeks to foster collaboration among physicians and scientists in the two countries.

1 Mar 2005

More dependable, less expensive tool to help detect bladder cancer earlier

Researchers at The University of Texas M. D. Anderson Cancer Center found that a simple test that can be administered and read in the doctor's office was three times more effective than a conventional laboratory test for detecting bladder cancer.

15 Feb 2005

Green tea extract has potential as an anti-cancer agent

A new study on bladder cancer cells lines shows that green tea extract has potential as an anti-cancer agent, proving for the first time that it is able to target cancer cells while leaving healthy cells alone.

15 Feb 2005

Medical device innovations - fabricating the future

Two large pieces of metal lie on the floor of what looks like a mini-factory in the Cleveland Clinic’s Lerner Research Institute. The whirring machinery here stamps out prototypes of medical devices imagined by clinicians and researchers to help with diagnostic testing or surgical procedures.

9 Jan 2005

Hypnosis helps kids undergoing difficult procedure called voiding cystourethography

Elaine Miller desperately wanted to find a way to help her daughter, Hannah, endure an awkward and painful medical examination in which doctors insert a catheter into her bladder, inject a dye and ask her to urinate while being X-rayed.

4 Jan 2005

Calcium intake contributing factor in formation of kidney stones

Individuals with either calcium oxalate or calcium phosphate kidney stones should not take extra calcium on their own as suggested by previous research, but should check with their doctors to determine the dietary guidelines that work best for them, researchers at UT Southwestern Medical Center at Dallas have found.

4 Jan 2005

FDA approves Enablex for the treatment of overactive bladder

Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.

22 Dec 2004

Notebook computers can have a negative effect on male fertility

US fertility experts are warning teenage boys and young men to consider limiting the time that they use notebook computers positioned on their laps, as long-term use may affect their fertility.

13 Dec 2004

New surgical procedure enables men born with a very small penis to acquire an average-sized one

A surgical procedure being pioneered by University College London (UCL) urologists is enabling men born with a very small penis to acquire an average-sized, functioning penis which not only allows them to urinate normally, but for many, to enjoy a full sex life for the first time.

6 Dec 2004

Hormone replacement therapy patches have considerable potential as prostate cancer therapy

Men using the female estrogen hormone replacement therapy (HRT) patches as treatment for advanced prostate cancer suffer fewer side effects than with other treatments, according to a new study reported in the latest issue of the Journal of Urology.

16 Nov 2004

$10 million to establish a multidisciplinary research program in cancer nanotechnology

The National Institutes of Health (NIH) has awarded scientists from Emory University and the Georgia Institute of Technology two new collaborative research grants, totaling nearly $10 million, to establish a multidisciplinary research program in cancer nanotechnology and to develop a new class of nanoparticles for molecular and cellular imaging.

6 Oct 2004